Silja Leiber
Doctoral dissertation, Ludwig-Maximilians-Universität München (LMU Munich), 2025.

This dissertation evaluates newly synthesized histone deacetylase inhibitors (HDACi) for diffuse large B-cell lymphoma (DLBCL). Forty-one HDACi compounds were screened across multiple lymphoma cell lines, and YAK477 emerged as a lead candidate with selective cytotoxicity in CREBBP-mutated lines. The work included FACS-based cell-cycle analysis, GFP labeling of DLBCL lines, and stromal co-culture models of the tumor microenvironment.

How Fluotics products were used: Automated 384-well liquid handling used a Fluotics CyBio TipTray (384/60 µL, catalog no. 736-0997).

Read the full publication